ARTICLE | Company News
Northwestern University, Panther Biotechnology deal
September 15, 2014 7:00 AM UTC
Panther received an option from the university to license exclusive, worldwide rights to numonafide. The preclinical cancer compound is a small molecule derivative of amonafide, a topoisomerase II (...